INNATE PHARMA EO -,05 | 2.640 / -2.94% |
Date/Time | 05/25 / 15:59 |
Chg. / Chg.(%) | -0.080 / -2.94% |
Bid | 2.502 / 500 |
Ask | 2.902 / 500 |
Open | 2.620 |
Previous Close | 2.720 |
High | 2.640 |
Low | 2.602 |
Volume [EUR] | - |
Volume [Units] | |
Price fixings | 8 |
ISIN | FR0010331421 |
Security | IDD |
Exchange | Stuttgart |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Euronext - P.. | 2.670 | ![]() |
67,991 |
Cboe Europe .. | 2.65 | ![]() |
1,061 |
London Inter.. | 2.672 | ![]() |
607 |
Düsseldorf | 2.648 | ![]() |
0 |
München | 2.678 | ![]() |
0 |
Berlin | 2.642 | ![]() |
0 |
Frankfurt | 2.6420 | ![]() |
0 |
Stuttgart | 2.640 | ![]() |
|
Lang & Schwa.. | 2.620 | ![]() |
|
gettex | 2.6440 | ![]() |
|
Quotrix | 2.6480 | ![]() |
|
TradeGate | 2.72 | 640 | |
Turquoise | 2.73 | ![]() |
24 |
Nasdaq Other.. | 2.8300 | 200 | |
Cboe Europe .. | 4.08 | 145 | |
Cboe Europe .. | 4.08 | 145 |
News
- Press Release: Strong 2021 sales and business EPS growth enabling increased investment in R&D
02/04/2022 / 07:30 - GlobeNewswire - Noema Pharma expands its Board of Directors with the appointments of Catherine Moukheibir and Ilise Lombardo
11/09/2021 / 14:55 - GlobeNewswire - Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021
09/23/2021 / 07:00 - GlobeNewswire - Monalizumab Data from COAST Trial Presented at ESMO Congress 2021
09/17/2021 / 13:45 - GlobeNewswire - Innate Pharma Reports First Half 2021 Financial Results and Business Update
09/15/2021 / 07:00 - GlobeNewswire